Sule Tinaz1. 1. Department of Neurology, Division of Movement Disorders, Yale University School of Medicine, 15 York St, LCI 710, New Haven, CT, 06510, USA. sule.tinaz@yale.edu.
Abstract
PURPOSE OF REVIEW: There has been an exponential growth in functional connectomics research in neurodegenerative disorders. This review summarizes the recent findings and limitations of the field in Parkinson's disease (PD) and atypical parkinsonian syndromes. RECENT FINDINGS: Increasingly more sophisticated methods ranging from seed-based to network and whole-brain dynamic functional connectivity have been used. Results regarding the disruption in the functional connectome vary considerably based on disease severity and phenotypes, and treatment status in PD. Non-motor symptoms of PD also link to the dysfunction in heterogeneous networks. Studies in atypical parkinsonian syndromes are relatively scarce. An important clinical goal of functional connectomics in neurodegenerative disorders is to establish the presence of pathology, track disease progression, predict outcomes, and monitor treatment response. The obstacles of reliability and reproducibility in the field need to be addressed to improve the potential of the functional connectome as a biomarker for these purposes in PD and atypical parkinsonian syndromes.
PURPOSE OF REVIEW: There has been an exponential growth in functional connectomics research in neurodegenerative disorders. This review summarizes the recent findings and limitations of the field in Parkinson's disease (PD) and atypical parkinsonian syndromes. RECENT FINDINGS: Increasingly more sophisticated methods ranging from seed-based to network and whole-brain dynamic functional connectivity have been used. Results regarding the disruption in the functional connectome vary considerably based on disease severity and phenotypes, and treatment status in PD. Non-motor symptoms of PD also link to the dysfunction in heterogeneous networks. Studies in atypical parkinsonian syndromes are relatively scarce. An important clinical goal of functional connectomics in neurodegenerative disorders is to establish the presence of pathology, track disease progression, predict outcomes, and monitor treatment response. The obstacles of reliability and reproducibility in the field need to be addressed to improve the potential of the functional connectome as a biomarker for these purposes in PD and atypical parkinsonian syndromes.
Authors: Johannes Rosskopf; Martin Gorges; Hans-Peter Müller; Dorothée Lulé; Ingo Uttner; Albert C Ludolph; Elmar Pinkhardt; Freimut D Juengling; Jan Kassubek Journal: Mov Disord Date: 2017-05-22 Impact factor: 10.338
Authors: Timothy O Laumann; Evan M Gordon; Babatunde Adeyemo; Abraham Z Snyder; Sung Jun Joo; Mei-Yen Chen; Adrian W Gilmore; Kathleen B McDermott; Steven M Nelson; Nico U F Dosenbach; Bradley L Schlaggar; Jeanette A Mumford; Russell A Poldrack; Steven E Petersen Journal: Neuron Date: 2015-07-23 Impact factor: 17.173
Authors: Meichen Yu; Kristin A Linn; Philip A Cook; Mary L Phillips; Melvin McInnis; Maurizio Fava; Madhukar H Trivedi; Myrna M Weissman; Russell T Shinohara; Yvette I Sheline Journal: Hum Brain Mapp Date: 2018-07-01 Impact factor: 5.038
Authors: Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan Journal: Mov Disord Date: 2017-05-03 Impact factor: 10.338
Authors: Alexandra Abós; Hugo C Baggio; Bàrbara Segura; Anna I García-Díaz; Yaroslau Compta; Maria José Martí; Francesc Valldeoriola; Carme Junqué Journal: Sci Rep Date: 2017-03-28 Impact factor: 4.379
Authors: Nailin Yao; Charlton Cheung; Shirley Pang; Richard Shek-kwan Chang; Kui Kai Lau; John Suckling; Kevin Yu; Henry Ka-Fung Mak; Siew Eng Chua; Shu-Leong Ho; Grainne M McAlonan Journal: Brain Struct Funct Date: 2014-10-07 Impact factor: 3.270
Authors: Bernard Ng; Gael Varoquaux; Jean Baptiste Poline; Bertrand Thirion; Michael D Greicius; Kathleen L Poston Journal: Neuroimage Clin Date: 2017-09-06 Impact factor: 4.881
Authors: Mario Quarantelli; Andrea Quattrone; Alessia Sarica; Francesco Cicone; Giuseppe Lucio Cascini; Aldo Quattrone Journal: NPJ Parkinsons Dis Date: 2022-09-28